Understanding the pathophysiology of myasthenia gravis is still being determined to this day, but the neonatal Fc receptor is emerging as a potential treatment.
Erin M. Burns, PhD, MSPH
Advertisement
Articles by Erin M. Burns, PhD, MSPH
Advertisement
Latest Updated Articles
- Targeting the Neonatal Fc Receptor in Myasthenia Gravis
Published: February 27th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
RWJBarnabas and Rutgers Health Researchers Pursue Advanced Neurostimulation Technology to Treat Epileptic Seizures
2
Parkinson Agent Tavapadon Shows Continued Efficacy, Safety in Phase 3 TEMPO-4 Trial
3
NeurologyLive® Brain Games: October 19, 2025
4
Elecsys pTau181 Test Cleared, Tividenofusp Alfa PDUFA Pushed Back, Phase 4 LOTUS Study Highlights Real-World Benefit of Trofinetide
5
